An observational study in Respiratory Insufficiency in Children, sponsored by Brno University Hospital. Recruiting at 1 site in Czechia. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2026-03-12.
Sponsored by Brno University Hospital · Observational
Transcutaneous capnometry (tPCO₂) is a non-invasive method for continuous monitoring of ventilation status. In pediatric intensive care patients, it may reduce the need for repeated arterial or arterialized blood sampling. However, the accuracy of tPCO₂ may be influenced by factors such as peripheral perfusion, skin temperature, and vasopressor therapy. This prospective observational study compares transcutaneous carbon dioxide measurements with arterialized or arterial blood gas PaCO₂ values in children with respiratory insufficiency, including a subgroup receiving vasopressor support.
This prospective observational study will be conducted in a pediatric intensive care unit to assess agreement between transcutaneous carbon dioxide monitoring and arterialized or arterial blood gas analysis. Consecutive pediatric patients aged 1-18 years with respiratory insufficiency or impaired peripheral perfusion requiring vasopressor support will be included if repeated blood gas sampling is clinically indicated.
Paired measurements of tPCO₂ and PaCO₂ will be analyzed using Bland-Altman methods with correction for repeated measures. Subgroup analyses will evaluate the influence of vasopressor therapy on measurement accuracy. Secondary analyses will compare tPO₂ and PaO₂ values. The study aims to define the clinical applicability and limitations of transcutaneous capnometry in critically ill pediatric patients.
Critically ill pediatric patients admitted to a tertiary PICU with respiratory insufficiency or circulatory compromise.
Exclusion Criteria:
Partial CO2 difference
Agreement between transcutaneous CO₂ (tPCO₂) and arterialized or arterial PaCO₂ assessed using Bland-Altman analysis (bias, SD, 95% limits of agreement).
Time frame: periprocedural
Proportion of pCO2
Proportion of tPCO₂ values within ±1 kPa of PaCO₂
Time frame: periprocedural
Partial O2
Agreement between transcutaneous oxygen (tPO₂) and PaO₂
Time frame: periprocedural
Vassopressor use
Subgroup analysis based on presence of vasopressor support
Time frame: periprocedural
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brno University Hospital